Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1426 participants.

Also called NCT02943785

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,426 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02943785
  • EudraCT 2016-003930-26
Other papers using this trial's data
  • Comparing Major Gastrointestinal Bleeding in Patients Receiving Edoxaban Versus Warfarin After Transcatheter Aortic Valve Replacement: Results From the Randomized ENVISAGE-TAVI AF Trial Journal of the American Heart Association, 2025-05-20 DOI, PubMed 40371611, PMC12184617 In the PMC Open Access subset under CC BY-NC-ND.
  • Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR The New England journal of medicine, 2021-12-02 DOI, PubMed 34449183

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Belgium, Canada, France, Germany, Italy, Japan, Netherlands, Poland, South Korea, Spain, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02943785. Randomized; no masking; primary purpose treatment. Start 2017-03-21 (actual); primary completion 2021-02-28 (actual). Results posted on 2022-03-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
Intervention (Drug)
Edoxaban-based Regimen
Intervention (Drug)
VKA-based Regimen
Lead sponsor
Daiichi Sankyo (class: industry)
Collaborator
Chiltern International Inc. (class: industry)

Record details

Record id
cardio:ct-nct02943785
Content hash
d47b07637500765d3fb6cddb42ba84cb636138ccc0a2364d5857a0a528892acf